Catheter Precision, Inc. (VTAK) Free cash flow 2017–2025
Catheter Precision, Inc. (VTAK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$8.3MFY2025 · since FY2017: -$6.1M → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.3M | +11.0% |
| FY2024 | -$9.3M | +54.9% |
| FY2023 | -$20.7M | +8.4% |
| FY2022 | -$22.6M | +19.0% |
| FY2021 | -$27.9M | +1.7% |
| FY2020 | -$28.4M | +15.2% |
| FY2019 | -$33.4M | -75.2% |
| FY2018 | -$19.1M | -214.5% |
| FY2017 | -$6.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VTAK financial trends
VTAK RevenueVTAK Net incomeVTAK Net marginVTAK Gross profitVTAK Gross marginVTAK Operating incomeVTAK Operating marginVTAK Operating cash flowVTAK Capital expendituresVTAK Return on equityVTAK Stock buybacksVTAK Dividends paidVTAK Total assetsVTAK Total liabilitiesVTAK Shareholders’ equityVTAK overview →